Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BLAU3.SA
Strong BuyBlau Farmacêutica S.A. · Healthcare · Brazil · $415M · Avg Vol: $461K/d
88
StockRankGet insider-trade alerts
Q
66
V
76
M
44
P/E (TTM)
9.0x
ROE
10.3%
D/E
0.4x
Dividend %
0.0%
COMPANY DESCRIPTION
Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4B | 1.4B | 1.8B | 1.7B | 6.6% | 1.8B | 1.9B | 2.2B | 13.8% |
| EPS (BRL) | 1.57 | 1.08 | 0.94 | 1.28 | -6.6% | 1.02 | 1.41 | 1.75 | 16.8% |
| Shares | 231.2M | 231.0M | 231.0M | 300.3M | +29.9% | 231.0M | — | — | — |
| Debt | 311.7M | 608.5M | 559.0M | 599.1M | 24.3% | 862.6M | — | — | — |
| Equity | 1.8B | 2.0B | 2.2B | 2.3B | 7.6% | — | — | — | — |
| Op CF | 171.9M | 220.6M | 507.2M | 290.8M | 19.2% | 429.1M | — | — | — |
| Inv CF | 133.0M | -356.8M | -314.7M | -154.7M | — | — | — | — | — |
| Fin CF | -342.6M | 153.6M | -190.7M | -120.3M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-1.0%
SMA 50SMA 200
Close
$1.75
RSI (14)
58.8
52W High
$2.74
From 52W High
0.6%
SCORE BREAKDOWN
Quality
66
ROIC
15.6%86.1
ROE
10.3%72.4
GP/Assets
20.3%47.3
Op. Margin
17.1%78.8
FCF/Assets
3.7%63.4
Piotroski
497.6
Int. Cover
3.7x49.2
D/E Ratio
0.37x37.2
Current Ratio
3.23x57.2
Value
76
P/E (TTM)
9.0x90.8
EV/EBITDA
5.7x89.9
P/FCF
15.9x69.8
P/B
0.9x87.2
P/S
1.2x80.6
Div Yield
0.0%0.1
Momentum
44
52W High %
64%39.8
RS 6M
-8%55.6
SMA 50/200
0.95x46.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+37%47.9
Q Growth
-16%26.8
FUNDAMENTALS
Market Cap
$415M
P/E (Forward)
6.5x
Gross Margin
41.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BLAU3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BLAU3.SA | Blau Farmacêutica S.A.(you) | $415M | 88 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| HYPE3.SA | Hypera S.A. | $3.0B | 97 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 97 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 75 | Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 98 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $93M | 87 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $636M | 59 | Hold |
| FLRY3.SA | Fleury S.A. | $2.0B | 99 | Strong Buy |
Peer medians: ROE 10.6% · P/E 13.3x · Gross margin 30.3%